Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
about
Immunotherapy for tularemiaM-Cells Contribute to the Entry of an Oral Vaccine but Are Not Essential for the Subsequent Induction of Protective Immunity against Francisella tularensisEvolutionary Insights into IL17A in LagomorphsDifferential Cultivation of Francisella tularensis Induces Changes in the Immune Response to and Protective Efficacy of Whole Cell-Based Inactivated VaccinesIdentification of early interactions between Francisella and the host.IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infectionFc receptor-targeting of immunogen as a strategy for enhanced antigen loading, vaccination, and protection using intranasally administered antigen-pulsed dendritic cellsBacterial programming of host responses: coordination between type I interferon and cell death.Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivoDoes Type I Interferon Limit Protective Neutrophil Responses during Pulmonary Francisella Tularensis Infection?Francisella Inflammasomes: Integrated Responses to a Cytosolic Stealth Bacterium.Yin and yang of interleukin-17 in host immunity to infection.Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.A Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.
P2860
Q26864945-FCA1E813-7CB6-4AE0-A04F-E510DCEC135AQ27314549-48035582-01D5-4995-877C-876E0336858FQ30383669-73684B96-F245-4084-BA9D-3CC2CCC83655Q30834372-6DF63A67-52EC-46C7-A93F-D0E56008103BQ33602941-A602C4F4-C25E-4B41-89E9-E82080D485ABQ33822265-B16C2B94-8D6B-49DA-8C29-021CB516DE6DQ34087802-70E644E5-90C7-4176-8DEF-D2BBEDCFF404Q34414006-CCC445E1-F5DC-4D4B-BF3D-9C1287A678BBQ36226550-1975090F-445A-4771-A8E9-1D8BA75865A9Q38237641-56CC7A06-C767-4420-98F6-CF3B446C3D85Q38909303-AB6D94E6-0406-425E-8E10-D094A102493FQ39438071-22CE2B68-E8E4-42F2-8D67-9B65E3514180Q41993864-9AA417A8-3EDB-4E40-B9D2-7658C345B528Q47663406-BC50872F-F53F-499A-A380-A7C665D3CA32Q52571082-53A3E497-3ABF-432A-B682-E5ED6BE81C5A
P2860
Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@en
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@nl
type
label
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@en
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@nl
prefLabel
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@en
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@nl
P2093
P2860
P356
P1476
Interleukin-17 protects agains ...... t F. tularensis type A strain.
@en
P2093
David W Pascual
Jerod A Skyberg
Joshua W Samuel
Marjorie D Sutherland
Maryclare F Rollins
P2860
P304
P356
10.1128/IAI.00203-13
P407
P577
2013-06-17T00:00:00Z